Table 2 Clinical features of irradiated patients
Bone – based image guided group (BB) N = 89 | Fiducial – based image guided group (FB) N = 91 | |||
|---|---|---|---|---|
Characteristics | Number (%) | Characteristics | Number (%) | p |
T stage | T stage | 0.93 | ||
1 | 36 (41%) | 1 | 39 (43%) | |
2 | 42 (47%) | 2 | 38 (42%) | |
3 | 8 (9%) | 3 | 13 (14%) | |
4 | 3 (3%) | 4 | 1 (1%) | |
Gleason score | Gleason score | |||
6 | 56 (63%) | 6 | 43 (47%) | 0.66 |
7 | 23 (26%) | 7 | 32 (35%) | |
8 | 7 (8%) | 8 | 10 (11%) | |
9 | 1 (1%) | 9 | 6 (7%) | |
10 | 2 (2%) | 10 | 0 (0%) | |
Highest PSA | Highest PSA | |||
Range (ng/ml) | 3.41–150.00 | Range (ng/ml) | 1.97–143.00 | 0.36 |
Median | 14.50 | Median | 14.12 | |
Mean | 27.31 | Mean | 22.84 | |
Risk group | Risk group | |||
Low | 19 (21%) | Low | 13 (14%) | 0.84 |
Intermediate | 32 (36%) | Intermediate | 42 (46%) | |
High | 38 (43%) | High | 36 (40%) | |
Hormonal therapy | Hormonal therapy | |||
Yes | 77 (87%) | Yes | 81 (89%) | 0.61 |
No | 12 (13%) | No | 10 (11%) | |
Symptoms | Symptoms | |||
Urinary | Urinary | 0.01 | ||
Yes | 42 (47%) | Yes | 27 (30%) | |
No | 47 (53%) | No | 64 (70%) | |
Intestinal | Intestinal | 0.45 | ||
Yes | 5 (6%) | Yes | 3 (3%) | |
No | 84 (94%) | No | 88 (97%) | |
Cardiovascular disease | Cardiovascular disease | 0.01 | ||
Yes | 46 (52%) | Yes | 64 (70%) | |
No | 43 (48%) | No | 27 (30%) | |